Literature DB >> 11774953

Tissue viral load variability in chronic hepatitis C.

L Fanning1, J Loane, E Kenny-Walsh, M Sheehan, M Whelton, W Kirwan, J K Collins, F Shanahan.   

Abstract

OBJECTIVE: Liver biopsy is regarded as the gold standard for assessing disease activity in chronic hepatitis C, but sampling error is a potential limitation. Whether sampling variability applies equally to viral load assessment as it does to histology is uncertain. To examine this, we compared viral load between right- and left-lobe biopsy specimens from patients infected with hepatitis C virus (HCV).
METHODS: Bilobe biopsies were taken from 16 patients who were serum positive for HCV RNA by reverse transcription-polymerase chain reaction. Genotype was identified by reverse line probe hybridization. There was an absence of competing risk factors for infectious and other liver diseases in this patient group. Histology and hepatic viral load were assessed blindly. None of the patients had received antiviral therapy at the time of study.
RESULTS: Detection of HCV in right and left lobes was concordant with serum positivity in all cases. The viral load between lobes was highly correlated (p = 0.0003, r = 0.79). In contrast, the histological activity indices of inflammation and fibrosis/cirrhosis were poorly correlated between lobes (p = 0.038, r = 0.60, and p = 0.098, r = 0.50, respectively).
CONCLUSION: Hepatic viral load variability does not suffer from the same degree of heterogeneity of sampling variability as does histology.

Entities:  

Mesh:

Year:  2001        PMID: 11774953     DOI: 10.1111/j.1572-0241.2001.05271.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  6 in total

1.  Variability of grade and stage in simultaneous paired liver biopsies in patients with hepatitis C.

Authors:  Silvia Skripenova; Thomas D Trainer; Edward L Krawitt; Hagen Blaszyk
Journal:  J Clin Pathol       Date:  2006-05-12       Impact factor: 3.411

2.  Percentage of hepatitis C virus-infected hepatocytes is a better predictor of response than serum viremia levels.

Authors:  Elena Rodríguez-Iñigo; Juan Manuel López-Alcorocho; Javier Bartolomé; Nuria Ortiz-Movilla; Margarita Pardo; Vicente Carreño
Journal:  J Mol Diagn       Date:  2005-10       Impact factor: 5.568

3.  Influence of liver biopsy heterogeneity and diagnosis of nonalcoholic steatohepatitis in subjects undergoing gastric bypass.

Authors:  Janani Arun; Niraj Jhala; Audrey J Lazenby; Ronald Clements; Gary A Abrams
Journal:  Obes Surg       Date:  2007-02       Impact factor: 4.129

4.  Effect of tumour necrosis factor alpha antagonists on serum transaminases and viraemia in patients with rheumatoid arthritis and chronic hepatitis C infection.

Authors:  J R Peterson; F C Hsu; P A Simkin; M H Wener
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

5.  High resolution sequencing of hepatitis C virus reveals limited intra-hepatic compartmentalization in end-stage liver disease.

Authors:  Ditte L Hedegaard; Damien C Tully; Ian A Rowe; Gary M Reynolds; David J Bean; Ke Hu; Christopher Davis; Annika Wilhelm; Colin B Ogilvie; Karen A Power; Alexander W Tarr; Deirdre Kelly; Todd M Allen; Peter Balfe; Jane A McKeating
Journal:  J Hepatol       Date:  2016-08-13       Impact factor: 25.083

6.  Serum proteomic analysis focused on fibrosis in patients with hepatitis C virus infection.

Authors:  Ian R White; Keyur Patel; William T Symonds; Anouk Dev; Philip Griffin; Nikos Tsokanas; Mark Skehel; Chiang Liu; Amany Zekry; Paul Cutler; Mahanandeeshwar Gattu; Don C Rockey; Michelle M Berrey; John G McHutchison
Journal:  J Transl Med       Date:  2007-07-11       Impact factor: 5.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.